4.5 Article Proceedings Paper

The importance of vaccine supply chains to everyone in the vaccine world

Journal

VACCINE
Volume 35, Issue 35, Pages 4475-4479

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2017.05.096

Keywords

Immunization; Supply chains; Logistics

Funding

  1. Bill and Melinda Gates Foundation
  2. Agency for Healthcare Research and Quality (AHRQ) [R01HS023317]
  3. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Office of Behavioral and Social Sciences Research (OBSSR)
  4. Global Obesity Prevention Center (GOPC) [U54HD070725]
  5. NICHD [U01HD086861]

Ask authors/readers for more resources

While the focus of many in the vaccine world has been on developing new vaccines and measuring their effects on humans, failure to understand and properly address vaccine supply chain issues can greatly reduce the impact of any vaccine. Therefore, everyone involved in vaccine decision-making may want to take into account supply chains when making key decisions. In fact, considering supply chain issues long before a vaccine reaches the market can help design vaccines and vaccine programs that better match the system. We detail how vaccine supply chains may affect the work and decision making of ten examples of different members of the vaccine community: preclinical vaccinologists, vaccine clinical trialists, vaccine package designers, health care workers, epidemiologists and disease surveillance experts, policy makers, storage equipment manufacturers, other technology developers, information system specialists, and funders. We offer ten recommendations to help decision makers better understand and address supply chains. (C) 2017 Published by Elsevier Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available